Abrdn PLC Ligand Pharmaceuticals Inc Transaction History

Abrdn PLC

$57.3 Billion
Q2 2025

A detailed history of Abrdn PLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Abrdn PLC holds 229,230 shares of LGND stock, worth $30.4 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

229,230

Previous 216,241 6.01%

Holding current value

$30.4 Million

Previous $22.7 Million 14.62%

% of portfolio

0.05%

Previous 0.05%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 24, 2025	BUY	$96.67 - $118.22 $1.26 Million - $1.54 Million	12,989 Added 6.01%	229,230 $26.1 Million
Q1 2025 May 13, 2025	BUY	$105.14 - $122.23 $4.15 Million - $4.83 Million	39,481 Added 22.34%	216,241 $22.7 Million
Q4 2024 Jan 24, 2025	SELL	$99.95 - $129.9 $7.25 Million - $9.42 Million	-72,509 Reduced 29.09%	176,760 $18.9 Million
Q3 2024 Oct 24, 2024	SELL	$82.7 - $110.11 $1.73 Million - $2.3 Million	-20,874 Reduced 7.73%	249,269 $25 Million
Q2 2024 Aug 09, 2024	SELL	$68.53 - $87.91 $782,132 - $1 Million	-11,413 Reduced 4.05%	270,143 $22.8 Million
Q1 2024 May 08, 2024	SELL	$68.64 - $89.2 $608,287 - $790,490	-8,862 Reduced 3.05%	281,556 $20.6 Million
Q4 2023 Jan 31, 2024	SELL	$49.57 - $72.63 $1.47 Million - $2.16 Million	-29,711 Reduced 9.28%	290,418 $20.7 Million
Q3 2023 Nov 06, 2023	SELL	$58.86 - $72.67 $4.04 Million - $4.99 Million	-68,671 Reduced 17.66%	320,129 $19.2 Million
Q2 2023 Jun 20, 2024	BUY	$69.53 - $79.33 $7.45 Million - $8.5 Million	107,093 Added 38.02%	388,800 $28 Million
Q2 2023 Aug 04, 2023	BUY	$69.53 - $79.33 $7.45 Million - $8.5 Million	107,093 Added 38.02%	388,800 $28 Million
Q1 2023 Jun 20, 2024	SELL	$65.67 - $77.08 $1.79 Million - $2.1 Million	-27,272 Reduced 8.83%	281,707 $20.7 Million
Q1 2023 Apr 28, 2023	SELL	$65.67 - $77.08 $1.79 Million - $2.1 Million	-27,272 Reduced 8.83%	281,707 $20.7 Million
Q4 2022 Jun 20, 2024	BUY	$61.72 - $96.74 $1.69 Million - $2.65 Million	27,423 Added 9.74%	308,979 $20.6 Million
Q4 2022 Feb 09, 2023	SELL	$61.72 - $96.74 $8.23 Million - $12.9 Million	-133,380 Reduced 30.15%	308,979 $20.6 Million
Q3 2022 Nov 10, 2022	BUY	$0.01 - $107.56 $137 - $1.48 Million	13,774 Added 3.21%	442,359 $38.1 Million
Q2 2022 Aug 05, 2022	BUY	$74.52 - $117.06 $6.97 Million - $11 Million	93,582 Added 27.93%	428,585 $38.2 Million
Q1 2022 May 04, 2022	SELL	$94.99 - $151.56 $2.61 Million - $4.16 Million	-27,466 Reduced 7.58%	335,003 $37.7 Million
Q4 2021 Feb 08, 2022	BUY	$127.69 - $165.85 $549,960 - $714,315	4,307 Added 1.2%	362,469 $56 Million
Q3 2021 Nov 15, 2021	SELL	$102.33 - $144.73 $4.87 Million - $6.89 Million	-47,614 Reduced 11.73%	358,162 $49.9 Million
Q2 2021 Aug 10, 2021	BUY	$113.03 - $155.64 $26.1 Million - $36 Million	231,294 Added 132.56%	405,776 $53.2 Million
Q1 2021 May 06, 2021	SELL	$99.52 - $215.83 $19.4 Million - $42 Million	-194,599 Reduced 52.73%	174,482 $26.6 Million
Q4 2020 Feb 10, 2021	BUY	$80.55 - $106.05 $13.9 Million - $18.3 Million	172,089 Added 87.36%	369,081 $36.7 Million
Q3 2020 Oct 21, 2020	BUY	$89.56 - $126.72 $17.6 Million - $25 Million	196,992 New	196,992 $18.8 Million

Others Institutions Holding LGND

# of Institutions

280

Shares Held

19M

Call Options Held

9.5K

Put Options Held

8.1K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.24B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.

Account